TipRanks
Advertisement
Advertisement
Myriad Genetics downgraded to Underweight from Overweight at Piper Sandler
PremiumThe FlyMyriad Genetics downgraded to Underweight from Overweight at Piper Sandler
15d ago
Analyst Cuts Myriad Genetics to Sell, Slashes Price Target to $2 Amid Structural Profitability Concerns
Premium
Ratings
Analyst Cuts Myriad Genetics to Sell, Slashes Price Target to $2 Amid Structural Profitability Concerns
15d ago
Myriad Genetics price target lowered to $3 from $5 at Stephens
Premium
The Fly
Myriad Genetics price target lowered to $3 from $5 at Stephens
29d ago
Myriad Genetics cuts FY26 revenue view to $770M-$790M from $860M-$880M
PremiumThe FlyMyriad Genetics cuts FY26 revenue view to $770M-$790M from $860M-$880M
2M ago
Myriad Genetics reports Q2 EPS (25c), consensus (6c)
Premium
The Fly
Myriad Genetics reports Q2 EPS (25c), consensus (6c)
2M ago
MYGN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
MYGN Earnings this Week: How Will it Perform?
2M ago
Myriad Genetics price target lowered to $6 from $7 at TD Cowen
PremiumThe FlyMyriad Genetics price target lowered to $6 from $7 at TD Cowen
4M ago
Myriad Genetics Bets on Growth Amid Profit Squeeze
Premium
Company Announcements
Myriad Genetics Bets on Growth Amid Profit Squeeze
4M ago
MYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100